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SUMMARY – Atrial fi brillation is associated with systemic embolization and complications due 
to anticoagulant therapy. Radiofrequency ablation has been established as an eff ective and safe meth-
od for the treatment of atrial fi brillation. Th e aim of this study was to evaluate the eff ect of the size of 
the left atrium on the outcome of surgical radiofrequency ablation. Forty patients scheduled for elec-
tive mitral valve surgery and radiofrequency ablation were enrolled in the study. Group 1 consisted of 
patients with a left atrium diameter ≤5 cm and group 2 of patients with left atrium diameter >5 cm. 
Th e primary endpoint of the study was stable sinus rhythm 6 months postoperatively. At 6 months 
postoperatively, sinus rhythm was present in signifi cantly more group 1 patients as compared with 
group 2 patients, i.e. 15 (75%) vs. 8 (40%), p=0.025. Multivariate analysis proved the size of the left 
atrium to be an independent predictor of the radiofrequency ablation outcome. Accordingly, the size 
of the left atrium was demonstrated to be an important predictor of the outcome of radiofrequency 
ablation for atrial fi brillation. A lower cut-off  value of surgical reduction of the atria than previously 
reported should be considered in order to improve the radiofrequency ablation outcome.
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Introduction
Atrial fi brillation (AF) is found in about 4% of the 
general population aged >60 and in about 9% of those 
aged >80, which makes it the most common cardiac 
arrhythmia in the general population1. It is a global 
healthcare problem and with the ongoing aging of the 
general population, its prevalence and incidence is es-
timated to double in the next 50 years2-4. It has major 
medical and economic implications, as it is associated 
with compromised cardiac function, systemic emboli-
zation, and complications associated with anticoagu-
lant therapy, resulting in higher mortality, morbidity, 
and prolonged hospital stay4-8. Th e traditional anti-ar-
rhythmic medications for AF are limited in long-term 
effi  ciency and have signifi cant and sometimes fatal ad-
verse events9.
Depending on the cardiac pathology, over 58% of 
patients with mitral valvular heart disease had electro-
cardiographically documented AF with adverse hemo-
dynamic eff ects before cardiac surgery10,11. Although 
the Cox-Maze III cut-and-sew procedure provides 
excellent short- and long-term results both in convert-
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ing AF to sinus rhythm and preventing thromboem-
bolic complications, it is not widely accepted among 
surgeons due to its technical complexity and long du-
ration12-15. As a consequence, bipolar radiofrequency 
ablation (RFA) has been established as a simple, eff ec-
tive and safe alternative method capable of creating 
fast transmural tissue lesions of the atrial myocardi-
um16,17. It provides a shorter time of surgery and re-
duces the risk of perioperative complications6,7,12,13.
Risk factors such as the size of the left atrium (LA)18-
20, AF duration20, persistent vs. paroxysmal AF18,19,21, fe-
male gender22, higher CHADS2 score23,24, presence of 
hypertension18,25, coronary artery disease19, and meta-
bolic syndrome26 have all been correlated with a less fa-
vorable success of ablation. Among them, larger LA size 
remains one of most cited predictors of long-term abla-
tion outcome18-21,27,28. However, the  results of these stud-
ies have so far been contradictory and rather inconclu-
sive. Furthermore, there are no clear recommendations 
at what atrial size an LA  reduction procedure should be 
considered. Th e aim of this study was therefore to evalu-
ate the eff ect of the 5-cm threshold LA size on the out-
come of surgical RFA in patients undergoing elective 
mitral valve  surgery.
Patients and Methods
Th e study was conducted in patients scheduled for 
elective mitral valve surgery and concomitant RFA for 
permanent atrial fi brillation between September 2008 
and December 2009. Th e study protocol was approved 
by the institutional medical ethics committee and in 
full accordance with the World Medical Association 
Declaration of Helsinki.
Exclusion criteria included emergency surgery, AF 
lasting for less than 6 months, and severe systolic dys-
function of the left ventricle (ejection fraction <25%). 
Once the patient was considered eligible for enrol-
ment, she/he was informed about the study protocol 
and a written informed consent was obtained. Th e pa-
tients were divided into two groups regarding the LA 
diameter. Group 1 consisted of patients with LA di-
ameter ≤5 cm and group 2 consisted of patients whose 
LA diameter was greater than 5 cm. Th e LA diameter 
was measured echocardiographically as the end-sys-
tolic anteroposterior linear dimension obtained from 
the parasternal long axis view. Twenty consecutive pa-
tients were included in each group.
In addition to the preoperative echocardiogram, 
basic demographic, laboratory, and medical data were 
obtained and recorded before surgery. Patients in both 
groups received the same preoperative medical pre-
medication and underwent the same anesthesia proto-
col. All patients underwent standard full sternotomy 
and cardiopulmonary bypass with mild hypothermia. 
Antegrade and retrograde cold blood cardioplegia was 
used for cardiac protection. Th e ablation procedure 
was performed with the Medtronic Cardioblate bipo-
lar RFA clamp.
Radiofrequency ablation around the right and left 
pulmonary vein orifi ces, as well as around the base of 
the LA appendage was usually performed before 
clamping the aorta. After the aortic cross-clamping, 
two connecting lesions were made on the LA posterior 
wall between both islands of pulmonary veins (box le-
sion). Th e LA appendage was closed from the atrial 
side using a running polypropylene 4/0 suture.
Intraoperatively, surgical data such as cardiopul-
monary bypass time, aortic cross-clamp time and type 
of surgery on mitral valve were recorded. Postopera-
tively, both groups underwent the same routine post-
operative intensive care unit (ICU) and ward care. All 
patients received amiodarone intravenously 300-600 
mg b.i.d. for the fi rst 3 postoperative days. Afterwards, 
or when the patient’s condition allowed, amiodarone 
was continued orally in a dose of 200 mg daily. In case 
of a relapse of AF, electroconversion was performed 
after a thrombus in the LA was excluded with trans-
esophageal echocardiogram (TEE). In case of severe 
bradycardia (<50/min), amiodarone was discontinued. 
A permanent pacemaker was implanted in case of 
long-standing bradycardia (>10 days). All patients re-
ceived oral anticoagulation therapy with warfarin for 6 
months regardless of their heart rhythm, with a target 
INR 2.5-3.5.
All patients underwent a 6-month follow-up. Post-
operative electrocardiograms (ECGs) were used to as-
sess heart rhythm. Th ey were performed routinely be-
fore discharge from the hospital and afterwards at 3 
and 6 months after the surgery. Additional ECGs were 
performed at the discretion of the referring physicians. 
If the patient was found to be in AF, conversion to si-
nus rhythm was attempted with electroconversion. A 
TEE was performed prior to conversion if the patient 
was not adequately anticoagulated for the last 6 weeks. 
In addition to ECG, a transthoracic echocardiogram 
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was performed 6 months after the surgery. To declare 
a patient to be in normal sinus rhythm, in addition to 
an ECG, sinus rhythm had to be confi rmed echo-
graphically as well.
Th e primary endpoint of the study was the per-
centage of patients who were in sinus rhythm 6 months 
after the surgery.
Continuous variables were compared using the 
Student’s t-test for parametric and Mann-Whitney U 
test for nonparametric data. A paired-sample t-test 
was used to compare preoperative and postoperative 
echocardiogram data. Categorical variables were ana-
lyzed using χ2-test or Fisher exact test, as appropriate. 
Additionally, a binary logistic regression model was 
constructed using factors found to be signifi cant in 
univariate analyses (p<0.05) to assess the independent 
correlates to sinus rhythm after 6-month follow-up. 
All statistical analyses were performed using the SPSS 
22.0 software (IBM Corporation, Armonk, NY, USA).
Results
A total of 40 patients were included in the study, 
with 20 patients in each study group. Th e results are 
reported as mean ± standard deviation for continuous 
data and frequencies (percentages) for categorical data. 
Th e groups were well matched for baseline demo-
graphics, preoperative medications, and comorbidities 
(Table 1). Th e mean LA diameter diff erence between 
the study groups was 15.8 mm (mean diameter was 
45.6±4.6 mm in group 1 and 61.4±6.8 mm in group 2; 
p<0.001).
Both groups had similar intraoperative characteris-
tics with no signifi cant diff erences regarding cardio-
pulmonary bypass time, aortic cross-clamp time, and 
the ratio of mitral valve repair/replacement (Table 2).
Th e postoperative heart rhythm is shown in Table 
3. No signifi cant diff erences between the study groups 
could be detected regarding the heart rhythm at dis-
charge from the hospital. Similarly, no statistically sig-
nifi cant diff erences were identifi ed three months after 
the surgery. However, after 6 months, signifi cantly 
more patients were found to be in sinus rhythm in 
group 1 as compared to group 2 (15 (75%) vs. 8 (40%); 
p=0.025).
Th e binary logistic regression analysis demonstrat-
ed the LA size larger than 5 cm to be an independent 
predictor of the success of surgical RFA. In addition to 
the LA size, patient age and preoperative left ventricu-
lar ejection fraction (LVEF) also proved to be inde-
pendent predictors of the success of surgical RFA 
(Table 4).




(LA >50 mm) p value
LA diameter 
(mm) 45.6±4.6 61.4±6.8 <0.001
Age (yrs) 67.7±11.8 71.8±6.9 0.197
Male sex 13 (65%) 11 (55%) 0.519
Smoking 6 (30%) 8 (40%) 0.507
Body mass 
index (kg/m2) 25.6±4.0 27.5±12.5 0.766
Diabetes 
mellitus 4 (20%) 2 (10%) 0.376
LVEF (%) 49.2±9.6 49.6±10.1 0.886
Mitral valve 
stenosis 7 (35%) 7 (35%) 0.999
Preoperative 
ß-blocker 14 (70%) 17 (85%) 0.451
Preoperative 
ACEI/ARB 17 (85%) 18 (90%) 0.633
Preoperative 
digoxin 12 (60%) 12 (60%) 0.999
LA = left atrium; LVEF = left ventricular ejection fraction; ACEI = 
angiotensin converting enzyme inhibitor; ARB = angiotensin 
 receptor blocker




(LA >50 mm) p value
CPB time 

























LA = left atrium; CPB = cardiopulmonary bypass; MV = mitral 
valve, TV = tricuspid valve; AVR = aortic valve replacement; CABG 
= coronary artery bypass grafting
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Regarding the echocardiogram 6 months after the 
surgery, a signifi cant decrease in the LA diameter 
compared to the preoperative values was detected in 
both groups (Fig. 1). However, there were no signifi -
cant diff erences when comparing the mean LVEF be-
fore the surgery to the values 6 months after the sur-
gery in either group (group 1: 49.2±9.6% vs. 
47.4±8.8%, p=0.205; and group 2: 49.6±10.1% vs. 
47.9±8.5%; p=0.157).
Eventually, as summarized in Table 5, analysis of 
the postoperative course and complications did not 
show any diff erences between the groups. Th e length 
of ICU stay and overall hospitalization time did not 
diff er between the groups. No lethal outcomes and 
neurologic adverse events were observed in the study. 
Th ere were no sternal wound infections either.
Discussion
Chronic volume and pressure overload due to mi-
tral valve disease results in dilatation and structural LA 
changes. Although the exact mechanisms remain un-
clear, mechanical stretching itself, along with conse-
quent histologic changes such as fi brosis, necrosis and 
atrophy alter the electrical characteristics of the atrial 
myocardium. Unidirectional conduction blocks, pro-
longed circuit lengths, non-homogeneous repolariza-
tion, and altered refractory periods are the underlying 
electrophysiological substrates for triggering and main-
taining the re-entrant circuits of AF28,29.
It has been shown that AF and LA size are mutu-
ally interdependent. Many studies have confi rmed LA 




(LA >50 mm) p value
SR at discharge 16 (80%) 13 (70%) 0.288
SR at 3 months 16 (80%) 11 (55%) 0.091
SR at 6 months 15 (75%) 8 (40%) 0.025
LA = left atrium; SR = sinus rhythm







Age (yrs) -0.144 0.966 0.756-0.992 0.039
LA size 
>5 cm -1.939 0.144 0.024-0.863 0.034
Preoperative 
LVEF 0.106 1.112 1.008-1.227 0.034
LA = left atrium; LVEF = left ventricular ejection fraction




(LA >50 mm) p value
ICU stay 










LA = left atrium; ICU = intensive care unit
Fig. 1. Left atrium diameter: preoperative vs. 6 months 
postoperatively.
Group 1: 45.6±4.6 mm vs. 42.4±5.3 mm, p<0.001; 
group 2: 61.4±6.8 mm vs. 59.1±6.8 mm, p=0.008.
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dilatation as the cause of AF30,31, and vice versa, AF was 
also shown to be the cause of LA enlargement32. Al-
though mitral valve surgery is mandatory to eliminate 
the pressure and volume overload of the LA, it is by 
itself inadequate to induce spontaneous conversion to 
sinus rhythm33. Th ese fi ndings indicate irreversible un-
derlying histologic and electrophysiological changes in 
the atrial myocardium. Th erefore, an additional abla-
tive procedure is necessary to effi  caciously restore sinus 
rhythm.
In this study, the mean LA size at 6 months after 
the surgery was signifi cantly smaller compared to the 
preoperative values in both groups. As we did not per-
form any surgical reduction of the left atria, we assume 
that this was due to a combined eff ect of both mitral 
valve surgery and the ablative procedure. However, the 
clinical consequence of this size reduction is question-
able as the mean postoperative reduction of the LA 
diameter in groups 1 and 2 was only 3.2 mm and 2.3 
mm, respectively.
In general, the reported long-term success rate of 
RFA for AF in patients with AF and mitral valve sur-
gery varies from 65% to 90%34,35. Th e results of our 
study are consistent with these reports, however, only 
in the group of patients with the left atria smaller than 
5 cm. In the group with the larger left atria, we ob-
served a signifi cantly worse outcome as only 40% of 
the patients remained in sinus rhythm at the 6-month 
follow-up period. Th ese results highlight the impor-
tance of good and consistent long-term follow-up of 
these patients. Th is is particularly important in pa-
tients with larger atria. In the group of patients with 
the left atria larger than 5 cm, the number of patients 
with stable sinus rhythm 6 months after the procedure 
nearly halved compared to the number of patients who 
were in sinus rhythm at the time of discharge from the 
hospital (8 vs. 13 patients).
Left atrial size is certainly one of the most cited 
predictors of the outcome of RFA for AF18-21. How-
ever, despite a large body of data and studies currently 
available, the results are often contradictory and in-
conclusive. In many cases, it is still diffi  cult for a sur-
geon to foresee the success of a concomitant RFA pro-
cedure and to recognize the circumstances where pro-
longed procedure time, the risk of potential complica-
tions, and additional fi nancial burden are warranted.
Many clinical investigators have set thresholds of 
the LA diameter in order to predict the effi  cacy of sur-
gical treatment of AF. Melo et al.36 report the bound-
ary of 5.5 cm, Yin et al.37 set the threshold at 5.8 cm 
and Cao et al.38 at 6.8 cm. Similarly, Isobe et al.39 rec-
ommend LA reduction procedure only in patients 
with an LA diameter larger than 80 mm and a chest 
x-ray cardio-thoracic ratio greater than 70%.
However, with regard to the results of our study, a 
lower threshold value of the LA diameter is to be con-
sidered where additional measures for improving the 
outcome of RFA should be considered (biatrial lesion 
set, atrial reduction procedure).
Numerous studies have reported better results of 
RFA using both left- and right-sided atrial lesion40,41. 
However, isolated LA ablation is still widely used and 
extensively studied worldwide, both in open and espe-
cially in minimally invasive procedures42-45. Further-
more, many recent studies report that the limited, left 
side-only lesions are not only eff ective43, but may pro-
vide equivalent results as biatrial lesion sets46-48.
Th ere also are some important limitations of this 
study, which need to be mentioned. Firstly, it was a 
relatively small, single-center study with only 40 in-
cluded patients and a follow-up period of only 6 
months. Th e identifi cation of sinus rhythm relied on 
repetitive ECG recordings; no 24-hour Holter or con-
tinuous subcutaneous monitoring was implemented to 
detect potential paroxysms of AF. Furthermore, several 
diff erent ablation technologies exist nowadays that use 
diff erent energy sources to create tissue lesions; among 
them, radiofrequency and cryoablation are the most 
widely used. Because the present study focused only on 
(bipolar) RFA, the results may at least partially be also 
dependent on the ablation technology used.
In conclusion, although with some limitations, our 
study suggests that a suboptimal outcome of RFA is to 
be expected in mitral valve patients with larger LA. A 
lower cut-off  value for reduction of the atria, as previ-
ously reported, may therefore be considered. Future 
research is warranted to better determine this thresh-
old and to evaluate if additional right atrial lesions 
and/or an atrial reduction procedure could improve 
the outcomes of RFA in patients with LA diameter 
larger than 5 cm.
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Sažetak
UTJECAJ VELIČINE LIJEVOG ATRIJA NA PERZISTENTNI SINUSNI RITAM 
KOD BOLESNIKA KOJI SE PODVRGAVAJU KIRURGIJI MITRALNOG ZALISTKA 
I KONKOMITANTNOJ BIPOLARNOJ RADIOFREKVENTNOJ ABLACIJI
H. Avdagić, S. Sijerčić Avdagić, M. Pirić Avdagić i M. Antonič
Atrijska fi brilacija je povezana sa sistemskom embolizacijom i komplikacijama povezanim s antikoagulantnom terapijom. 
Radiofrekventna ablacija se preporuča kao učinkovita i sigurna metoda za liječenje atrijske fi brilacije. Cilj ove studije bio je 
procijeniti učinke veličine lijevog atrija na ishod operativne radiofrekventne ablacije. Studija je provedena na 40 bolesnika 
predviđenih za elektivno operativno liječenje bolesti mitralne valvule i radiofrekventne ablacije zbog trajne atrijske fi brilacije. 
Bolesnici su podijeljeni u dvije skupine prema veličini lijevog atrija. U prvoj skupini bili su bolesnici s lijevim atrijem  promjera 
≤5 cm, dok su u drugoj skupini bili bolesnici s promjerom lijevog atrija preko 5 cm. Primarni cilj studije bio je postotak 
 bolesnika u stabilnom sinusnom ritmu 6 mjeseci nakon operacije. Rezultati zabilježeni 6 mjeseci nakon operacije pokazali su 
značajno više bolesnika u sinusnom ritmu u prvoj skupini u usporedbi s drugom skupinom: 15 (75%) prema 8 (40%), 
p=0,025. Multivarijantna analiza je dokazala veličinu lijevog atrija kao neovisan prediktor za uspjeh operativne radiofrekventne 
ablacije. Zaključuje se da je veličina lijevog atrija važan čimbenik o kojem ovisi uspješnost operativne radiofrekventne abla cije. 
Za poboljšanje rezultata ablacije trebalo bi u obzir uzeti niže vrijednosti za operativnu redukciju atrija od onih preporučenih 
u prijašnjim izvješćima.
Ključne riječi: Atrijska fi brilacija; Antikoagulansi; Kateterska ablacija; Srčane pretklijetke; Kardiokirurški zahvati; Multivari-
jantna analiza
